| Jul 25 |
Nasdaq 100 Falls To 7-Week Lows, Marks Worst 2-Day Drop In Nearly 2 Years As Tech Rout Rages On
|
| Jul 25 |
Gilead Sciences to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024
|
| Jul 25 |
Gilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and Pipeline
|
| Jul 25 |
3 Stocks That Can Help You to Get Richer in 2024 and Beyond
|
| Jul 24 |
Gilead Sciences: The Upcycle Is Just Getting Started
|
| Jul 24 |
Full Efficacy and Safety Results for Gilead Investigational Twice-Yearly Lenacapavir for HIV Prevention Presented at AIDS 2024
|
| Jul 23 |
Invest $50K in CVS Health and Gilead Sciences to Become a Dividend Millionaire
|
| Jul 23 |
ViiV's Dovato as effective as Gilead's Biktarvy for HIV but with less weight gain
|
| Jul 23 |
ViiV Healthcare’s Dovato as effective as Biktarvy in Phase IV HIV trial
|
| Jul 23 |
Nanotechnology in medicine: Who are the leading public companies?
|
